Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in RZLT — Rezolute, Inc.

CIK 1214717 BOSTON, MA
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,284,800
+$5,293,506 QoQ
Shares Held
2,170,154
+10.5% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 144 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. RZLT ranks #181 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in RZLT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,284,800 2,170,154
2026-03-31 $5,991,294 1,964,359
2025-12-31 $4,613,169 1,954,733
2025-09-30 $17,365,408 1,847,384
2025-06-30 $7,631,251 1,711,043
2025-03-31 $1,644,905 567,209
2024-12-31 $2,533,368 517,014
2024-09-30 $2,384,264 491,601
2024-06-30 $1,520,892 353,696
2024-03-31 $859,834 337,190
2023-12-31 $260,810 262,649
2023-09-30 $346,696 262,649
2023-06-30 $496,734 250,876
2023-03-31 $481,681 250,876
2022-12-31 $519,313 250,876
2022-09-30 $679,169 247,872
2022-06-30 $607,527 188,089
2022-03-31 $233,182 68,989